ANXA2 and lung carcinoma: ANXA2 interacted with T-cell immunoglobulin and mucin domain-containing molecule 4 (TIM-4) and mediated TIM-4-induced lung cancer progression by activating PI3K/AKT/OPA1 axis [36].